Skip to main content
TipRanks
Go Ultimate75% OFF

Taiwan Bio Therapeutics Co., Ltd. (6892) Cash flow

Taiwan Bio Therapeutics Co., Ltd. Cash Flow

TW:6892's free cash flow for Q2 2025 was NT$-59.74M. For the 2025 fiscal year, TW:6892's free cash flow was decreased by NT$-11.35M and operating cash flow was NT$-48.39M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -212.31MNT$ -252.40MNT$ -166.55MNT$ -139.99MNT$ -59.16M
NT$ -152.89MNT$ -104.52MNT$ -119.23MNT$ -103.17MNT$ -178.97M
NT$ -26.68MNT$ 786.01MNT$ 290.43MNT$ 429.35MNT$ 261.33M
NT$ 290.39MNT$ 677.69MNT$ 248.14MNT$ 245.89MNT$ 59.70M
NT$ -244.42MNT$ -363.25MNT$ -285.78MNT$ -223.16MNT$ -233.85M

Currency in TWD

Taiwan Bio Therapeutics Co., Ltd. Cash Flow

-500M-250M0250M500M750M1B2019202020212022202320242025OperatingInvestingFinancing